Does BVS pay a dividend?

The cached stock data on this page does not show a positive dividend yield for BVS. Dividend status can change, so verify the latest company filings before relying on income assumptions.

What does BVS stock do?

Medical device provider specializing in non-invasive pain management, joint preservation, restorative therapies, and surgical bone grafting sold to hospitals, clinics, and physicians.

What is BVS stock's price target?

This cached page does not contain a precise model fair value for BVS.

The TradeMates model verdict for BVS is HOLD with an investment score of 63/100. Treat this as a model signal to review, not a personal buy recommendation.

Is BVS a good dividend stock?

BVS is not presented as a dividend idea on this cached TradeMates page because no positive dividend yield is available in the cached data.

BVS (BVS) Stock Analysis

Q: Is BVS stock a good investment?

The cached TradeMates AI model rates BVS as HOLD with an investment score of 63/100. The model score of 63/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.

Verdict: HOLD

Deleveraging and FCF expansion drive valuation rerating, but slow 3.1% top-line growth and $311M debt load constrain swift upside.

Investment score: 63/100

The model score of 63/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.

Peers

ICUI
NEOG
XRAY
UFPT
STAA

Peer	P/E	P/B	P/S	EV/EBITDA	ROIC %	Net margin %
ICUI	133.15	1.86	1.85	16.69	—	0.01
NEOG	-416.57	1.44	3.46	21.06	—	-0.01
XRAY	-3.54	1.43	0.53	23.35	—	-0.15
UFPT	30.41	4.76	3.49	20.19	—	0.11
STAA	252.87	2.79	2.97	27.91	—	0.01

View the full interactive analysis